(Q51803160)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19238334%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

title

The expression of COX-2, hTERT, MDM2, LATS2 and S100A2 in different types of non-small cell lung cancer (NSCLC) (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19238334%20AND%20SRC:MED&resulttype=core&format=json

non-small-cell lung carcinoma

22 January 2020

main subject

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19238334%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

author name string

Vid Mlakar

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19238334%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Damjan Glavac

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19238334%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

publication date

23 February 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19238334%20AND%20SRC:MED&resulttype=core&format=json

Cellular & Molecular Biology Letters

22 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19238334%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

volume

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19238334%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19238334%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

page(s)

442-456

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19238334%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.2478/s11658-009-0011-7

22 January 2020

exact match

0 references

cites work

Telomerase expression in lung preneoplasia and neoplasia

1 reference

https://api.crossref.org/works/10.2478%2FS11658-009-0011-7

Lung cancer and cyclooxygenase-2

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS11658-009-0011-7

Differential expression of S100A2 and S100A4 in lung adenocarcinomas: clinicopathological significance, relationship to p53 and identification of their target genes

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS11658-009-0011-7

MDM2 promotes proteasome-dependent ubiquitin-independent degradation of retinoblastoma protein.

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS11658-009-0011-7

Retinoic acid receptor beta and telomerase catalytic subunit expression in bronchial epithelium of heavy smokers

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS11658-009-0011-7

Smoking is associated with increased telomerase activity in short-term cultures of human bronchial epithelial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS11658-009-0011-7

Cyclooxygenase-2 is involved in S100A2-mediated tumor suppression in squamous cell carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS11658-009-0011-7

Specific Association of Human Telomerase Activity with Immortal Cells and Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS11658-009-0011-7

S100 family members and trypsinogens are predictors of distant metastasis and survival in early-stage non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS11658-009-0011-7

Differential response between the p53 ubiquitin-protein ligases Pirh2 and MdM2 following DNA damage in human cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS11658-009-0011-7

Enhanced Mdm2 activity inhibits pRB function via ubiquitin-dependent degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS11658-009-0011-7

Early onset lung cancer, cigarette smoking and the SNP309 of the murine double minute-2 (MDM2) gene

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS11658-009-0011-7

LATS2-Ajuba complex regulates gamma-tubulin recruitment to centrosomes and spindle organization during mitosis

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS11658-009-0011-7

p14ARF induces G2 arrest and apoptosis independently of p53 leading to regression of tumours established in nude mice

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS11658-009-0011-7

Cyclooxygenase-2 in human non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS11658-009-0011-7

A positive feedback loop between the p53 and Lats2 tumor suppressors prevents tetraploidization

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS11658-009-0011-7

Mdm2 is required for inhibition of Cdk2 activity by p21, thereby contributing to p53-dependent cell cycle arrest

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS11658-009-0011-7

Expression of human telomerase reverse transcriptase (hTERT) protein is significantly associated with the progression, recurrence and prognosis of oral squamous cell carcinoma in Taiwan.

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS11658-009-0011-7

Low LATS2 mRNA level can predict favorable response to epirubicin plus cyclophosphamide, but not to docetaxel, in breast cancers.

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS11658-009-0011-7

The MDM2 gene amplification database

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS11658-009-0011-7

Differential expression of telomerase reverse transcriptase (hTERT) in lung tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS11658-009-0011-7

Putative tumor suppressor Lats2 induces apoptosis through downregulation of Bcl-2 and Bcl-x(L).

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS11658-009-0011-7

Molecular portrait of cisplatin induced response in human testis cancer cell lines based on gene expression profiles

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS11658-009-0011-7

Regulation of p53 stability

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS11658-009-0011-7

Down-regulation of LATS1 and LATS2 mRNA expression by promoter hypermethylation and its association with biologically aggressive phenotype in human breast cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS11658-009-0011-7

Promoter hypermethylation-mediated down-regulation of LATS1 and LATS2 in human astrocytoma

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS11658-009-0011-7

p53 and its downstream proteins as molecular targets of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS11658-009-0011-7

Prognostic significance of cyclooxygenase 2 mRNA expression in non-small cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS11658-009-0011-7

The calcium-binding protein S100A2 interacts with p53 and modulates its transcriptional activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS11658-009-0011-7

Molecular genetics of lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS11658-009-0011-7

Lats2/Kpm is required for embryonic development, proliferation control and genomic integrity

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS11658-009-0011-7

Characterization of the genomic structure, chromosomal location and promoter of human prostaglandin H synthase-2 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS11658-009-0011-7

Lats2, a putative tumor suppressor, inhibits G1/S transition

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS11658-009-0011-7

Wild-type p53 overexpression and its correlation with MDM2 and p14ARF alterations: an alternative pathway to non-small-cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS11658-009-0011-7

A genetic screen implicates miRNA-372 and miRNA-373 as oncogenes in testicular germ cell tumors

21 January 2018

1 reference

12 December 2020

A selective cyclooxygenase-2 inhibitor suppresses tumor growth in nude mouse xenografted with human head and neck squamous carcinoma cells

1 reference

12 December 2020

Overexpression of S100A2 protein as a prognostic marker for patients with stage I non small cell lung cancer

1 reference

12 December 2020

Indomethacin and telomerase activity in tumor growth retardation

1 reference

12 December 2020

Prognostic significance of cyclooxygenase 2 expression in 259 cases of non-small cell lung cancer.

1 reference

12 December 2020

Downregulation of the large tumor suppressor 2 (LATS2/KPM) gene is associated with poor prognosis in acute lymphoblastic leukemia

1 reference

12 December 2020

Altered expression of the cell cycle regulatory molecules pRb, p53 and MDM2 exert a synergetic effect on tumor growth and chromosomal instability in non-small cell lung carcinomas (NSCLCs)

1 reference

12 December 2020

Increased expression of cyclooxygenase 2 occurs frequently in human lung cancers, specifically in adenocarcinomas

1 reference

12 December 2020

Telomerase activity in small-cell and non-small-cell lung cancers

1 reference

12 December 2020

S100A2 is strongly expressed in airway basal cells, preneoplastic bronchial lesions and primary non-small cell lung carcinomas

1 reference

12 December 2020

Immunohistochemical expression of cyclooxygenase isoenzymes and downstream enzymes in human lung tumors.

1 reference

12 December 2020

MDM2 mRNA expression is a favorable prognostic factor in non-small-cell lung cancer

1 reference

12 December 2020

Synergistic tumor suppression by coexpression of FUS1 and p53 is associated with down-regulation of murine double minute-2 and activation of the apoptotic protease-activating factor 1-dependent apoptotic pathway in human non-small cell lung cancer c

1 reference

12 December 2020

Prognostic significance of hTERT expression in non-small cell lung cancer

1 reference

12 December 2020

Expression of cyclooxygenase-1 and cyclooxygenase-2 in bronchial epithelium and nonsmall cell lung carcinoma

1 reference

12 December 2020

Diminished expression of S100A2, a putative tumor suppressor, at early stage of human lung carcinogenesis.

1 reference

12 December 2020

Expression of cyclooxygenase-2 in human lung carcinoma

1 reference

12 December 2020

Prognostic factors in resected stage I non-small-cell lung cancer: a multivariate analysis of six molecular markers

1 reference

12 December 2020

Prognostic significance of elevated cyclooxygenase 2 expression in primary, resected lung adenocarcinomas

1 reference

12 December 2020

hTERT expression is a prognostic factor of survival in patients with stage I non-small cell lung cancer

1 reference

12 December 2020

10.2478/S11658-009-0011-7

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19238334%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

22 January 2020

1 reference

9 September 2019

https://scigraph.springernature.com/pub.10.2478/s11658-009-0011-7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19238334%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

PubMed publication ID

19238334

1 reference